MICHIGAN STATE UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1855-02-12
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.msu.edu
Clinical Trials
134
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (117 trials with phase data)• Click on a phase to view related trials
Empowering Vietnamese Americans
- Conditions
- HPV VaccinationCancer Prevention
- First Posted Date
- 2025-09-10
- Last Posted Date
- 2025-09-10
- Lead Sponsor
- Michigan State University
- Target Recruit Count
- 60
- Registration Number
- NCT07164391
OMT & Intractable Singultus
- Conditions
- Hiccup
- First Posted Date
- 2025-08-29
- Last Posted Date
- 2025-08-29
- Lead Sponsor
- Michigan State University
- Target Recruit Count
- 5
- Registration Number
- NCT07149025
- Locations
- 🇺🇸
MSU OMM Clinic, East Lansing, Michigan, United States
Multilevel Community-Centered Intervention to Reduce Pregnancy Related and Associated Morbidity and Mortality (PRAMM) Disparities
- Conditions
- Provider ConfidenceProvider Behavior
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Michigan State University
- Target Recruit Count
- 480
- Registration Number
- NCT07025057
- Locations
- 🇺🇸
Strong Beginings, Grand Rapids, Michigan, United States
How Simplified Language Affects Comprehension and Learning in Young Children With Down Syndrome
- Conditions
- Down Syndrome
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Michigan State University
- Target Recruit Count
- 30
- Registration Number
- NCT06951516
- Locations
- 🇺🇸
Michigan State University, East Lansing, Michigan, United States
Support for Bereaved Cancer Caregivers
- Conditions
- BereavementCancerCaregiverGrief
- First Posted Date
- 2024-10-28
- Last Posted Date
- 2025-09-11
- Lead Sponsor
- Michigan State University
- Target Recruit Count
- 70
- Registration Number
- NCT06662409
- Locations
- 🇺🇸
Michigan State University College of Nursing, East Lansing, Michigan, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 27
- Next
News
PSMA PET Imaging Transforms Prostate Cancer Management with Multiple FDA-Approved Agents
PSMA PET imaging has revolutionized prostate cancer detection and management, particularly in biochemical recurrence settings, with multiple FDA-approved agents now available including gallium-68 PSMA-11, piflufolastat F 18, and flotufolastat F 18.
First Human Transplant of Sperm-Producing Stem Cells Offers Hope for Childhood Cancer Survivors
• A 26-year-old bone cancer survivor has received the first known transplant of sperm-producing stem cells preserved from his childhood, marking a significant advancement in fertility preservation for pediatric cancer patients. • Approximately one-third of childhood cancer survivors face infertility from treatments, with prepubertal patients having limited options as they cannot bank mature reproductive cells before therapy. • The experimental procedure, developed at the University of Pittsburgh Medical Center, follows successful animal studies and represents a potential breakthrough in oncofertility, though researchers caution results remain uncertain.